Non-invasive prenatal testing
NIPT is a highly accurate prenatal screening test that analyses foetal DNA in the mother’s blood for potential chromosomal abnormalities such as Down syndrome. This test can be performed as early as 10th week of gestation through a simple and safe blood draw.
Painless and highly accurate
Through our partnering laboratories carefully selected by our in-house experts, Cordlife offers non-invasive prenatal testing ("NIPT") services to expectant mothers through obstetricians in Singapore, Indonesia and the Philippines.
NIPT is a relatively new and highly accurate prenatal screening test that analyses foetal DNA in the mother’s blood for potential foetal chromosomal abnormalities, including Down syndrome, Edwards syndrome and Patau syndrome. The test can be performed as early as 10th week of gestation through a simple and safe blood draw.
NIPT uses cutting-edge Next Generation Sequencing technology for testing which provides an accuracy rate of over 99%.3 This is much higher than current conventional maternal marker-based prenatal tests which vary from 80% to 95%. This means that as many as 20% of abnormal foetus which were potentially missed from convention screening can now be detected by NIPT. Moreover, conventional tests carry a high false positive rate of 5% or more, which means that as many as 1 in 20 women undergoing screening will be subjected to invasive and risky confirmatory tests unnecessarily.4
Due to the availability of more reliable non-invasive prenatal screening tests such as NIPT, the American College of Obstetricians and Gynaecologists now recommends all pregnant women, regardless of age, to be offered screening for foetal chromosomal abnormalities.5
3. Non-Invasive Prenatal Testing NIPT Factsheet. National Coalition for Health Professional education in Genetics. November 2012
4. Practice Bulletin No. 163 Screening for Fetal Aneuploidy. American College of Obstetrics & Gynaecologists. May 2016, 127(5):e123-e137
5. ACOG Newsroom. The American Congress of Obstetricians and Gynaecologists Website. http://www.acog.org/about-acog/news-room/news-releases/2007/Acog-Screening-Guidelines-on-chromosomal-Abnormalities. Accessed August 2017
The most validated non-invasive prenatal testing (NIPT) that screens for the most common chromosomal abnormalities including Down syndrome. Testing performed in a CAP-accredited facility.
NICE® non-invasive prenatal testing screens for the most common chromosomal abnormalities that can affect your developing baby's future.